BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ikewaki N, Rao KS, Archibold AD, Iwasaki M, Senthilkumar R, Preethy S, Katoh S, Abraham SJK. Coagulopathy associated with COVID-19 - Perspectives & Preventive strategies using a biological response modifier Glucan. Thromb J 2020;18:27. [PMID: 33082714 DOI: 10.1186/s12959-020-00239-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Preethy S, Raghavan K, Dedeepiya VD, Surya Prakash V, Ikewaki N, Ikeue Y, Nagataki M, Iwasaki M, Senthilkumar R, Abraham SJK. Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis. Front Immunol 2022;13:870632. [DOI: 10.3389/fimmu.2022.870632] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ikewaki N, Kurosawa G, Kisaka T, Abraham SJK. Controlled modulation of all the arms of the immunity including innate immunity by biological response modifier glucans, a simple yet potential nutritional supplement strategy to fight COVID ‐19. Journal of Food Biochemistry. [DOI: 10.1111/jfbc.14156] [Reference Citation Analysis]
3 Srivastava S, Garg I, Dogra V, Bargotya M, Bhattar S, Gupta U, Jain S, Hussain J, Hembrom AA, Ghosh N, Kumar V, Varshney R, Ganju L. Implications of COVID-19 on Thrombotic Profile of Severely Affected Patients. Pathobiology 2022;:1-11. [PMID: 35344951 DOI: 10.1159/000522543] [Reference Citation Analysis]
4 Ikewaki N, Raghavan K, Dedeepiya VD, Vaddi S, Iwasaki M, Senthilkumar R, Preethy S, Abraham SJ. Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulans AFO-202 and N-163 produced beta glucans in Sprague Dawley rats. Clinical Immunology Communications 2021;1:29-34. [DOI: 10.1016/j.clicom.2021.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Raghavan K, Dedeepiya VD, Suryaprakash V, Rao KS, Ikewaki N, Sonoda T, Levy GA, Iwasaki M, Senthilkumar R, Preethy S, Abraham SJ. Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study. Biomed Pharmacother 2022;145:112243. [PMID: 34840031 DOI: 10.1016/j.biopha.2021.112243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Mirończuk-Chodakowska I, Kujawowicz K, Witkowska AM. Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era. Nutrients 2021;13:3960. [PMID: 34836215 DOI: 10.3390/nu13113960] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Bhansali S, Bagrodia V, Choudhury S, Rahman S, Golder M, Tiwari M, Kumar H. Spectrum of hospitalized NeuroCOVID diagnoses from a tertiary care neurology centre in Eastern India. J Clin Neurosci 2021;93:96-102. [PMID: 34656269 DOI: 10.1016/j.jocn.2021.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chaudhari V, Buttar HS, Bagwe-Parab S, Tuli HS, Vora A, Kaur G. Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents. Front Nutr 2021;8:646988. [PMID: 34262922 DOI: 10.3389/fnut.2021.646988] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Ropa J, Trinh T, Aljoufi A, Broxmeyer HE. Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters. Curr Opin Hematol 2021;28:231-42. [PMID: 33656463 DOI: 10.1097/MOH.0000000000000645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ikewaki N, Dedeepiya VD, Iwasaki M, Abraham SJK. Commentary: Beyond "TRIM" Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19. Front Immunol 2021;12:620658. [PMID: 33854499 DOI: 10.3389/fimmu.2021.620658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ali AM, Kunugi H. Approaches to Nutritional Screening in Patients with Coronavirus Disease 2019 (COVID-19). Int J Environ Res Public Health 2021;18:2772. [PMID: 33803339 DOI: 10.3390/ijerph18052772] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
12 Ikewaki N, Iwasaki M, Kurosawa G, Rao KS, Lakey-Beitia J, Preethy S, Abraham SJ. β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19. Hum Vaccin Immunother 2021;17:2808-13. [PMID: 33651967 DOI: 10.1080/21645515.2021.1880210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
13 Friedrich MS, Studt JD, Braun J, Spahn DR, Kaserer A. Coronavirus-induced coagulopathy during the course of disease. PLoS One 2020;15:e0243409. [PMID: 33332362 DOI: 10.1371/journal.pone.0243409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ikewaki N, Iwasaki M, Abraham SJK. Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients. J Diabetes Metab Disord 2020;:1-4. [PMID: 33102263 DOI: 10.1007/s40200-020-00664-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]